Clinical trials
Phase 3 Angina, Unstable trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 5 |
| 2005 | 4 |
| 2006 | 4 |
| 2007 | 2 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 5 |
| 2018 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 27 |
| Unknown status | 8 |
| Terminated | 2 |
| Recruiting | 1 |
| Suspended | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 2 |
| Centocor, Inc. | 2 |
| Collegium Medicum w Bydgoszczy | 2 |
| Karolinska Institutet | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Sanofi | 2 |
| AO GENERIUM | 1 |
| AstraZeneca | 1 |
| AtheroGenics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Angina, Unstable | 40 |
| Myocardial Infarction | 21 |
| Acute Coronary Syndrome | 19 |
| Non-ST Elevated Myocardial Infarction | 6 |
| Coronary Artery Disease | 5 |
| Coronary Disease | 5 |
| Heart Diseases | 5 |
| Myocardial Ischemia | 5 |
| Cardiovascular Diseases | 4 |
| Atherosclerosis | 3 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.